General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Khera M – Evidence shows that testosterone, added to estrogen therapy (ET), improves sexual function in women and may improve bone health. However, the absence of an FDA–approved agent, off–label use raises questions about patient selection, dosing, and safety. Approval of testosterone–containing preparations has been deferred pending confirmation of long–term safety assessments (2–5 years). Evidence suggests that testosterone supplementation does not increase the risk of breast cancer; it may have a protective effect on breast tissue. A longer time to disease progression and a higher response rate is observed when androgens are added to anti–estrogen therapy. Long–term androgen administration does not have significant, adverse effects on female breast tissue. Nevertheless, testosterone can still be aromatized to estrogen; patients with a history of estrogen–sensitive breast cancer should be discouraged from treatment. No convincing data suggest that testosterone use increases the risk of cardiovascular events in women. Although oral methyltestosterone has been shown to reduce HDL and raise LDL levels in women, this effect is not seen in association with other forms of testosterone. Finally, no evidence indicates that testosterone supplementation increases the risk of endometrial cancer.

Related Articles

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09    Relevance Score: 95%

Testosterone and biological characteristics of breast cancers in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09    Relevance Score: 94%

Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets
European Journal of Endocrinology, 11/17/09    Relevance Score: 91%

NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09    Relevance Score: 91%

NIH-Supported Trial to Study Testosterone Therapy in Older Men
NIH, 11/03/09    Relevance Score: 91%

Today in Women`s Health...keeping you current

Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/10/09

Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
International Journal of Cardiology, 12/10/09

Detecting breast cancer in a general practice - Like finding needles in a haystack?
Australian Family Physician, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address